BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29523405)

  • 1. Optimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injury.
    Yamanaka K; Eldeiry M; Aftab M; Mares J; Ryan TJ; Meng X; Weyant MJ; Cleveland JC; Fullerton DA; Reece TB
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2505-2516. PubMed ID: 29523405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Reduction of Apoptosis With Diazoxide and Erythropoietin in Spinal Cord Ischemic Injury.
    Yamanaka K; Eldeiry M; Aftab M; Ryan TJ; Mares J; Meng X; Weyant MJ; Cleveland JC; Fullerton DA; Reece TB
    Ann Thorac Surg; 2018 Dec; 106(6):1751-1758. PubMed ID: 30193997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergetic Induction of NGF With Diazoxide and Erythropoietin Attenuates Spinal Cord Ischemic Injury.
    Yamanaka K; Eldeiry M; Aftab M; Ryan TJ; Meng X; Weyant MJ; Fullerton DA; Reece TB
    J Surg Res; 2019 Jan; 233():124-131. PubMed ID: 30502238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment With Diazoxide Attenuates Spinal Cord Ischemia-Reperfusion Injury Through Signaling Transducer and Activator of Transcription 3 Pathway.
    Yamanaka K; Eldeiry M; Aftab M; Ryan TJ; Roda G; Meng X; Weyant MJ; Cleveland JC; Fullerton DA; Reece TB
    Ann Thorac Surg; 2019 Mar; 107(3):733-739. PubMed ID: 30395862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal Cord Ischemia-Reperfusion Injury Induces Erythropoietin Receptor Expression.
    Foley LS; Fullerton DA; Bennett DT; Freeman KA; Mares J; Bell MT; Cleveland JC; Weyant MJ; Meng X; Puskas F; Reece TB
    Ann Thorac Surg; 2015 Jul; 100(1):41-6; discussion 46. PubMed ID: 25865765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin activates the phosporylated cAMP [adenosine 3'5' cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injury.
    Mares JM; Foley LS; Bell MT; Bennett DT; Freeman KA; Meng X; Weyant MJ; Cleveland JC; Fullerton DA; Puskas F; Reece TB
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):920-4. PubMed ID: 25500291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin's Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons.
    Foley LS; Fullerton DA; Mares J; Sungelo M; Weyant MJ; Cleveland JC; Reece TB
    Ann Thorac Surg; 2017 Dec; 104(6):1909-1914. PubMed ID: 29100648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin preconditioning improves clinical and histologic outcome in an acute spinal cord ischemia and reperfusion rabbit model.
    Simon FH; Erhart P; Vcelar B; Scheuerle A; Schelzig H; Oberhuber A
    J Vasc Surg; 2016 Dec; 64(6):1797-1804. PubMed ID: 26610640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion.
    Bell MT; Puskas F; Bennett DT; Herson PS; Quillinan N; Fullerton DA; Reece TB
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):500-6. PubMed ID: 24035379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of insulin-like growth factor 1 and erythropoietin protects against ischemic spinal cord injury in rabbits.
    Utada K; Ishida K; Tohyama S; Urushima Y; Mizukami Y; Yamashita A; Uchida M; Matsumoto M
    J Anesth; 2015 Oct; 29(5):741-8. PubMed ID: 26003536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of angiotensin II type-1 receptor blockade with olmesartan on spinal cord ischemia-reperfusion injury: an experimental study on rats.
    Güler A; Sahin MA; Ucak A; Onan B; Inan K; Oztaş E; Arslan S; Uysal B; Demirkiliç U; Tatar H
    Ann Vasc Surg; 2010 Aug; 24(6):801-8. PubMed ID: 20638619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.
    Brines M; Grasso G; Fiordaliso F; Sfacteria A; Ghezzi P; Fratelli M; Latini R; Xie QW; Smart J; Su-Rick CJ; Pobre E; Diaz D; Gomez D; Hand C; Coleman T; Cerami A
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14907-12. PubMed ID: 15456912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.
    Bell MT; Agoston VA; Freeman KA; Puskas F; Herson PS; Mares J; Fullerton DA; Reece TB
    J Vasc Surg; 2014 Apr; 59(4):1090-7. PubMed ID: 23850057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed pharmacological pre-conditioning effect of mitochondrial ATP-sensitive potassium channel opener on neurologic injury in a rabbit model of spinal cord ischemia.
    Kim KO; Choe G; Chung SH; Kim CS
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):236-42. PubMed ID: 18005376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of spinal cord ischemia and reperfusion injury by erythropoietin.
    Smith PD; Puskas F; Fullerton DA; Meng X; Cho D; Cleveland JC; Weyant MJ; Reece TB
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):256-60. PubMed ID: 21168028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of spinal cord ischemia-reperfusion injury by specific α-2a receptor activation with dexmedetomidine.
    Bell MT; Puskas F; Smith PD; Agoston VA; Fullerton DA; Meng X; Weyant MJ; Reece TB
    J Vasc Surg; 2012 Nov; 56(5):1398-402. PubMed ID: 22832266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of spinal cord ischemia/reperfusion injury with simvastatin in rats.
    Saito T; Tsuchida M; Umehara S; Kohno T; Yamamoto H; Hayashi J
    Anesth Analg; 2011 Sep; 113(3):565-71. PubMed ID: 21680858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.
    Grasso G; Sfacteria A; Erbayraktar S; Passalacqua M; Meli F; Gokmen N; Yilmaz O; La Torre D; Buemi M; Iacopino DG; Coleman T; Cerami A; Brines M; Tomasello F
    J Neurosurg Spine; 2006 Apr; 4(4):310-8. PubMed ID: 16619678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.
    Celik M; Gökmen N; Erbayraktar S; Akhisaroglu M; Konakc S; Ulukus C; Genc S; Genc K; Sagiroglu E; Cerami A; Brines M
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2258-63. PubMed ID: 11854521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury.
    Kiziltepe U; Turan NN; Han U; Ulus AT; Akar F
    J Vasc Surg; 2004 Jul; 40(1):138-45. PubMed ID: 15218474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.